Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2

被引：279

作者：

Amary, M. Fernanda ^{[1
]}

Damato, Stephen ^{[1
]}

Halai, Dina ^{[1
]}

Eskandarpour, Malihe ^{[2
]}

Berisha, Fitim ^{[1
]}

Bonar, Fiona ^{[3
]}

McCarthy, Stan ^{[4
]}

Fantin, Valeria R. ^{[5
]}

Straley, Kimberly S. ^{[5
]}

Lobo, Samira ^{[1
]}

Aston, Will ^{[6
]}

Green, Claire L. ^{[2
]}

Gale, Rosemary E. ^{[2
]}

Tirabosco, Roberto ^{[1
]}

Futreal, Andrew ^{[7
]}

Campbell, Peter ^{[7
]}

Presneau, Nadege ^{[2
]}

Flanagan, Adrienne M. ^{[1
,2
]}

机构：

[1] Royal Natl Orthopaed Hosp Natl Hlth Serv Trust, Histopathol Unit, Stanmore, Middx, England

[2] Univ Coll London Canc Inst, London, England

[3] Douglass Hanly Moir Pathol, Sydney, NSW, Australia

[4] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia

[5] Agios Pharmaceut, Cambridge, MA USA

[6] Royal Natl Orthopaed Hosp Natl Hlth Serv Trust, Bone Tumour Unit, Stanmore, Middx, England

[7] Wellcome Trust Sanger Inst, Cambridge, England

来源：

NATURE GENETICS | 2011年 / 43卷 / 12期

基金：

英国惠康基金;

关键词：

ENCHONDROMATOSIS; GLIOMA;

D O I：

10.1038/ng.994

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Ollier disease and Maffucci syndrome are characterized by multiple central cartilaginous tumors that are accompanied by soft tissue hemangiomas in Maffucci syndrome. We show that in 37 of 40 individuals with these syndromes, at least one tumor has a mutation in isocitrate dehydrogenase 1 (IDH1) or in IDH2, 65% of which result in a R132C substitution in the protein. In 18 of 19 individuals with more than one tumor analyzed, all tumors from a given individual shared the same IDH1 mutation affecting Arg132. In 2 of 12 subjects, a low level of mutated DNA was identified in non-neoplastic tissue. The levels of the metabolite 2HG were measured in a series of central cartilaginous and vascular tumors, including samples from syndromic and nonsyndromic subjects, and these levels correlated strongly with the presence of IDH1 mutations. The findings are compatible with a model in which IDH1 or IDH2 mutations represent early post-zygotic occurrences in individuals with these syndromes.

引用

页码：1262 / U129

页数：5

共 50 条

[21] IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
C D DiNardo
E Jabbour
F Ravandi
K Takahashi
N Daver
M Routbort
K P Patel
M Brandt
S Pierce
H Kantarjian
G Garcia-Manero
Leukemia, 2016, 30 : 980 - 984
[22] The clinical use of IDH1 and IDH2 mutations in gliomas
Picca, Alberto
Berzero, Giulia
Di Stefano, Anna Luisa
Sanson, Marc
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (12) : 1041 - 1051
[23] IDH1 and IDH2 mutations in pediatric acute leukemia
A K Andersson
D W Miller
J A Lynch
A S Lemoff
Z Cai
S B Pounds
I Radtke
B Yan
J D Schuetz
J E Rubnitz
R C Ribeiro
S C Raimondi
J Zhang
C G Mullighan
S A Shurtleff
B A Schulman
J R Downing
Leukemia, 2011, 25 : 1570 - 1577
[24] IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
DiNardo, C. D.
Jabbour, E.
Ravandi, F.
Takahashi, K.
Daver, N.
Routbort, M.
Patel, K. P.
Brandt, M.
Pierce, S.
Kantarjian, H.
Garcia-Manero, G.
LEUKEMIA, 2016, 30 (04) : 980 - 984
[25] IDH1 and IDH2 mutations in pediatric acute leukemia
Andersson, A. K.
Miller, D. W.
Lynch, J. A.
Lemoff, A. S.
Cai, Z.
Pounds, S. B.
Radtke, I.
Yan, B.
Schuetz, J. D.
Rubnitz, J. E.
Ribeiro, R. C.
Raimondi, S. C.
Zhang, J.
Mullighan, C. G.
Shurtleff, S. A.
Schulman, B. A.
Downing, J. R.
LEUKEMIA, 2011, 25 (10) : 1570 - 1577
[26] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
Voss, J. S.
Kerr, S. E.
Fritcher, E. G. Barr
Highsmith, W. E.
Zhang, J.
Roberts, L. R.
Gores, G. J.
Halling, K. C.
Kipp, B. R.
LABORATORY INVESTIGATION, 2012, 92 : 184A - 184A
[27] Mutations of IDH1 and IDH2 are not frequent in Multiple Myeloma
Langer, C.
Ibanez, M.
Liebisch, P.
Zenz, T.
Knop, S.
Einsele, H.
Paschka, P.
Doehner, H.
Doehner, K.
ONKOLOGIE, 2011, 34 : 159 - 159
[28] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
Voss, J. S.
Kerr, S. E.
Fritcher, E. G. Barr
Highsmith, W. E.
Zhang, J.
Roberts, L. R.
Gores, G. J.
Halling, K. C.
Kipp, B. R.
MODERN PATHOLOGY, 2012, 25 : 184A - 184A
[29] Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders
Chotirat, Sadudee
Thongnoppakhun, Wanna
Wanachiwanawin, Wanchai
Auewarakul, Chirayu U.
BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (03) : 286 - 291
[30] Recurrent somatic IDH1 mutation in an adult with Maffucci syndrome
Brown, N. J.
Ye, Z.
Stutterd, C.
Schneider, A.
Mullen, S.
Mandelstam, S.
Scheffer, I. E.
Hildebrand, M. S.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1286 - 1286

← 1 2 3 4 5 →